Indo US Bio-Tech's ROE % for the quarter that ended in Mar. 2026 was 8.52%. Indo US Bio-Tech's PB Ratio for the quarter that ended in Mar. 2026 was 2.13.
Indo US Bio-Tech's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 4.00%.
Indo US Bio-Tech ROE % Adjusted to Book Value Related Terms
Indo US Bio-Tech ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indo US Bio-Tech ROE % Adjusted to Book Value Chart
NSE:INDOUS vs CTVA, CF, MOS: ROE % Adjusted to Book Value Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech ROE % Adjusted to Book Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 4.00% mean?
Indo US Bio-Tech (NSE:INDOUS) has a ROE % Adjusted to Book Value of 4.00% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Indo US Bio-Tech and its competitors.
Is Indo US Bio-Tech's ROE % Adjusted to Book Value too high?
Indo US Bio-Tech's current ROE % Adjusted to Book Value is 4.00%. Overall, Indo US Bio-Tech has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's ROE % Adjusted to Book Value compare to CTVA and CF?
Indo US Bio-Tech's ROE % Adjusted to Book Value of 4.00% can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for an Agriculture company?
A good ROE % Adjusted to Book Value depends on the Agriculture industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Indo US Bio-Tech and its competitors. Indo US Bio-Tech's current ROE % Adjusted to Book Value is 4.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹305.14, compared to a current price of ₹87.82 — trading 71.2% below its estimated fair value. The current ROE % Adjusted to Book Value is 4.00%. Indo US Bio-Tech's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current ROE % Adjusted to Book Value is 4.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹87.82 is trading 71.2% below its estimated GF Value™ of ₹305.14.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
ROE % Adjusted to Book Value: 4.00%
GF Value™: ₹305.14 vs. price of ₹87.82 (71.2% below fair value)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
69GF Score
Get the complete analysis for NSE:INDOUS
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
